Innova Captab

Innova Captab Debt/Market Cap

The Debt to Market Capitalization Ratio of Innova Captab (INNOVACAP.NS) as of Nov 22, 2026 is 8.92 %. In the previous year, Debt to Market Capitalization Ratio was 8.77 % — a change of 1.65% (higher).

Debt/Market Cap

8.92 %

YoY

1.65%

Last updated:

Debt to Market Capitalization Ratio of Innova Captab is 2026 8.92 % . Debt to Market Capitalization Ratio of Innova Captab was 2025 8.77 % . It decreases by 1.65% higher compared to the previous year.

The Innova Captab Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2019
2.23 INR
Jan 1, 2020
1.70 INR
Jan 1, 2021
1.18 INR
Jan 1, 2022
5.17 INR
Jan 1, 2023
6.15 INR
Jan 1, 2024
6.36 INR
Jan 1, 2025
8.77 INR
Jan 1, 2026
8.92 INR
The Innova Captab Debt/Market Cap history
YEARDebt/Market CapYoY
8.92 %+1.65%
8.77 %+37.95%
6.36 %+3.43%
6.15 %+18.98%
5.17 %+337.76%
1.18 %-30.50%
1.70 %-23.71%
2.23 %+12.91%
1.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innova Captab Stock analysis

What does Innova Captab do? Innova Captab Ltd generates revenue through its CDMO business, which offers research, product development, and manufacturing services to clients in the pharmaceutical sector. The company also earns from its domestic branded generics business, developing, manufacturing, and distributing generic formulation products under its own brand names across India via online and offline channels. Additionally, Innova Captab sells its generic drug products through various e-commerce pharmacy sites. The company's diversified portfolio includes tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. Its international branded generic product business focuses on exporting branded generic products globally. Innova Captab's primary customers are pharmaceutical companies seeking CDMO services, Indian consumers purchasing generic medicines through retail and online pharmacies, and international buyers of branded generic products. The domestic market segment is served through branded generics sold under the company's own brand names, while the international segment targets global markets for branded generic drug exports. The company's value chain spans research and development, manufacturing, drug distribution, marketing, and exports, ensuring comprehensive coverage across the pharmaceutical industry. The company's product segments include CDMO services, domestic branded generics, and international branded generics. CDMO services are provided to pharmaceutical firms requiring outsourced research and manufacturing. Domestic branded generics are marketed in India under the company's brand names through both online and offline channels. International branded generics are exported to global markets, leveraging the company's manufacturing capabilities and product portfolio. Innova Captab's business model integrates all stages of the pharmaceutical value chain, from R&D to exports, to deliver a full-service solution for its clients and customers. Innova Captab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innova Captab stock

Debt to Market Capitalization Ratio of Innova Captab is 8.92 % in 2026.

Debt to Market Capitalization Ratio of Innova Captab changed from 8.77 % to 8.92 %, representing a 1.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Innova Captab since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Innova Captab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Innova Captab

All Key Metrics — Innova Captab